Literature DB >> 2167606

Coxsackie B antigen in the central nervous system of a patient with fatal acute encephalitis: immunohistochemical studies of formalin-fixed paraffin-embedded tissue.

S Kamei1, S M Hersch, T Kurata, Y Takei.   

Abstract

A case of fatal acute encephalitis due to Coxsackie B1 virus is described. Confirmation of Coxsackie B virus as the etiological agent of encephalitis was based on identification of the virus antigen in formalin-fixed paraffin-embedded tissue sections. In the past, the diagnosis was obtained by serological studies of peripheral blood and viral isolation. This is the first report in which indirect immunofluorescent and immunoperoxidase methods using rabbit antiserum raised against Coxsackie B types 1-6 was utilized in determining the etiology of encephalitis. It must be emphasized that these methods can be used both on biopsy or autopsy specimens, even retrospectively.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167606     DOI: 10.1007/BF00308928

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  21 in total

1.  Severe generalized disease (encephalohepatomyocarditis) occurring in the newborn period and due to infection with Coxsackie virus, group B; evidence of intrauterine infection with this agent.

Authors:  S KIBRICK; K BENIRSCHKE
Journal:  Pediatrics       Date:  1958-11       Impact factor: 7.124

2.  Myocarditis in a newborn infant with encephalomeningitis due to Coxsackie virus group B, type 5.

Authors:  T B DELANEY; F H FUKUNAGA
Journal:  N Engl J Med       Date:  1958-07-31       Impact factor: 91.245

3.  Analysis of viral antigens in giant cells of measles pneumonia by immunoperoxidase method.

Authors:  T Sata; T Kurata; Y Aoyama; M Sakaguchi; K Yamanouchi; K Takeda
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

4.  A method for specific diagnosis of Rocky Mountain spotted fever on fixed, paraffin-embedded tissue by immunofluorescence.

Authors:  D H Walker; B G Cain
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

5.  Coxsackievirus B5 infection and aseptic meningitis in neonates and children.

Authors:  R Marier; W Rodriguez; R J Chloupek; C D Brandt; H W Kim; R S Baltimore; C L Parker; M S Artenstein
Journal:  Am J Dis Child       Date:  1975-03

6.  Meningo-encephalitis caused by Coxsackievirus group B type 2. Diagnosis confirmed by measuring intrathecal antibody.

Authors:  P E Klapper; A S Bailey; M Longson; B W Barton; G A Davies-Jones
Journal:  J Infect       Date:  1984-05       Impact factor: 6.072

7.  The clinical relevance of 'CSF viral culture'. A two-year experience with aseptic meningitis in Rochester, NY.

Authors:  T Chonmaitree; M A Menegus; K R Powell
Journal:  JAMA       Date:  1982-04-02       Impact factor: 56.272

8.  Passage of Coxsackie virus (Connecticut-5 strain) in adult mice with production of pancreatic disease.

Authors:  A M PAPPENHEIMER; L J KUNZ; S RICHARDSON
Journal:  J Exp Med       Date:  1951-07-01       Impact factor: 14.307

Review 9.  The enteroviruses: recent advances.

Authors:  H A Wenner
Journal:  Yale J Biol Med       Date:  1982 May-Aug

10.  Adaptation of Group B Coxsackie virus to adult mouse pancreas.

Authors:  G DALLDORF; R GIFFORD
Journal:  J Exp Med       Date:  1952-11       Impact factor: 14.307

View more
  10 in total

1.  Neural stem cell depletion and CNS developmental defects after enteroviral infection.

Authors:  Chelsea M Ruller; Jenna M Tabor-Godwin; Donn A Van Deren; Scott M Robinson; Sonia Maciejewski; Shea Gluhm; Paul E Gilbert; Naili An; Natalie A Gude; Mark A Sussman; J Lindsay Whitton; Ralph Feuer
Journal:  Am J Pathol       Date:  2011-12-31       Impact factor: 4.307

2.  Characterization of group B coxsackieviruses isolated from non-polio acute flaccid paralysis patients in Pakistan: vital assessment before polio eradication.

Authors:  M Angez; S Shaukat; R Zahra; M M Alam; S Sharif; A Khurshid; Y Arshad; M Suleman; G Mujtaba; S S Z Zaidi
Journal:  Epidemiol Infect       Date:  2017-07-25       Impact factor: 4.434

Review 3.  Viral parkinsonism.

Authors:  Haeman Jang; David A Boltz; Robert G Webster; Richard Jay Smeyne
Journal:  Biochim Biophys Acta       Date:  2008-08-12

4.  Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease.

Authors:  Ralph Feuer; Ignacio Mena; Robb R Pagarigan; Stephanie Harkins; Daniel E Hassett; J Lindsay Whitton
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

5.  Coxsackievirus B4 myocarditis and meningoencephalitis in newborn twins.

Authors:  Stephanie J Bissel; Caitlin C Winkler; Joseph DelTondo; Guoji Wang; Karl Williams; Clayton A Wiley
Journal:  Neuropathology       Date:  2014-04-07       Impact factor: 1.906

6.  Coxsackievirus B infection is highly related with missed abortion in Korea.

Authors:  Jung Hye Hwang; Jeong Wook Kim; Ji Young Hwang; Kyung Min Lee; Hye Min Shim; Young Kyung Bae; Seung Sam Paik; Hosun Park
Journal:  Yonsei Med J       Date:  2014-11       Impact factor: 2.759

7.  Establishment of a panel of in-house polyclonal antibodies for the diagnosis of enterovirus infections.

Authors:  Osamu Kotani; Naoko Iwata-Yoshikawa; Tadaki Suzuki; Yuko Sato; Noriko Nakajima; Satoshi Koike; Takuya Iwasaki; Tetsutaro Sata; Teruo Yamashita; Hiroko Minagawa; Fumihiro Taguchi; Hideki Hasegawa; Hiroyuki Shimizu; Noriyo Nagata
Journal:  Neuropathology       Date:  2014-09-28       Impact factor: 1.906

8.  Antenatal and postnatal diagnosis of coxsackie b4 infection: case series.

Authors:  Jennifer C Hunt; Carol Schneider; Savas Menticoglou; Jayantha Herath; Marc R Del Bigio
Journal:  AJP Rep       Date:  2011-11-25

Review 9.  Viruses and neurodegeneration.

Authors:  Li Zhou; Monica Miranda-Saksena; Nitin K Saksena
Journal:  Virol J       Date:  2013-05-31       Impact factor: 4.099

10.  Induction of cytopathic effect and cytokines in coxsackievirus B3-infected murine astrocytes.

Authors:  Jun Zeng; Gefei Wang; Weizhong Li; Dangui Zhang; Xiaoxuan Chen; Gang Xin; Zhiwu Jiang; Kangsheng Li
Journal:  Virol J       Date:  2013-05-21       Impact factor: 4.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.